5-(Bis(2-chloroethyl)amino)-1-methyl-2-benzimidazolebutyric acid
CAS: 16506-27-7
Ref. 3D-FB32117
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar |
Informação sobre produto
- Bendamustine
- 1H-Benzimidazole-2-butanoic acid, 5-[bis(2-chloroethyl)amino]-1-methyl-
- 2-Benzimidazolebutyric acid, 5-[bis(2-chloroethyl)amino]-1-methyl-
- 4-[5-[Bis(2-chloroethyl)amino]-1-methylbenzimidazol-2-yl]butanoic acid
- 4-{5-[Bis(2-chloroethyl)amino]-1-methyl-1H-benzimidazol-2-yl}butanoic acid
- 5-[Bis(2-chloroethyl)amino]-1-methyl-1H-benzimidazole-2-butanoic acid
- ω-[1-Methyl-5-[bis(β-chloroethyl)amino]-2-benzimidazolyl]butyric acid
5-(Bis(2-chloroethyl)amino)-1-methyl-2-benzimidazolebutyric acid (BCBA) is an experimental cancer drug that is being investigated for the treatment of a variety of cancers. BCBA inhibits the growth and proliferation of cancer cells by interfering with DNA synthesis and repair. BCBA has been shown to be effective in treating T cell lymphomas, as well as solid tumours such as carcinoma cell lines and breast cancer. The drug has also been used to treat hypersensitivity syndrome in many patients with infectious diseases.
Propriedades químicas
Consulta técnica sobre: 3D-FB32117 5-(Bis(2-chloroethyl)amino)-1-methyl-2-benzimidazolebutyric acid
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
